Indian Vaccines Industry

Published by: Cygnus Business Consulting and Research

Published: Mar. 8, 2008 - 143 Pages

Table of Contents

EXECUTIVE SUMMARY

HIGHLIGHTS

Introduction.

2. Market overview

2.1 Global market overview

2.1.1 Introduction

2.1.2 Market scenario

2.1.2.1 Market segmentation

2.1.2.2 Market trends

2.1.2.3 Major players

2.1.3 Major markets

2.1.3.1 USA

2.1.3.2 Europe

2.1.4 Outlook

2.2 Indian market overview

2.2.1 Introduction

2.2.2 Current Market scenario.

2.2.2.2 Market size

2.2.2.1 Market segment

2.2.2.3 Market trends

2.2.3 Outlook

3 Growth drivers

3.1 Increasing Population in Developing Countries

3.3 Diseases prevention

3.4 Blockbuster Potential of New Vaccines

3.5 Disease Awareness

3.6 India - Future Hub for Paediatric Vaccine Manufacturing

4 Issues and challenges

4.1 Vaccine Funding

4.2 Lack of infrastructure for Trials & Manufactures

4.3 Dependence on government by domestic companies

4.4 Timely Regulatory Clearance

4.5 Vaccine Supply

5 Critical success factors

5.1 Pricing.

5.2 Funding from Government & NGOs

5.3 Distribution network

5.4 Government immunisation programme

5.5 Storage Infrastructure

6. MAJOR PLAYERS

6.1. Serum Institute of India Ltd

6.2 Panacea Biotech Ltd.

6.3 Venkateshwara Hatcheries Private Ltd

6.4 Indian Immunological Ltd

6.5 GlaxoSmithKline Pharmaceuticals Ltd.

6.6 Aventis Pharma Limited

6.7 Shantha Biotechnics

6.8. Eli Lilly India

6.9. Haffkine Bio Pharmaceutical Corporation Ltd (HBCL)

6.10. Intervet India

7. Regulatory Environment.

7.1 U.S.A

7.2 Europe

7.3 India

8. Future outlook.

List of Tables

Table 2.1: Global vaccine companies revenue

Table 2.2: Key alliances of Sanofi-Aventis

Table 2.3: R&D pipeline of Sanofi-Aventis

Table 2.4: Segmental revenue in Biopharma sector

Table 2.5: Products segment in the vaccine market

Table 2.6: Top ten vaccine players in India

Table 2.7: Major vaccines

Table 2.8: Vaccines launched in India

Table 3.1: Combination of vaccines

Table 3.2: New combination of vaccines

Table 6.1: Top ten players in India biopharma sector

Table 7.1: Some bio piracy patents based on indigenous knowledge of India

List of Figures

Figure 2.1: Geographical segments of vaccine markets

Figure 2.2: Global vaccine market

Figure 2.3 Sanofi-aventis vaccine segment

Figure 2.4: Glaxo Smith Kline vaccine segment

Figure 2.5: Novartis vaccine segment region wise

Figure 2.6: Merck vaccine segment

Figure 2.7: Segment wise biopharma sales contribution

Figure 2.8: Segment wise biopharma sales contribution

Figure 2.9: Indian vaccine market

Figure 2.10: Segment wise contribution in the animal vaccine market

Figure 2.11: Major players in Indian poultry vaccine market

Figure 8.1: Indian biopharmaceutical market forecast

Figure 8.2 Indian vaccine market forecast

Abstract

• A market assessment of vaccines segment with reference to the market size and market trend is presented.
• Vaccines report presents the growth drivers such as increasing population, disease awareness etc.
• It presents the issues and challenges involved in vaccines with reference to vaccine funding, timely regulatory clearance.
• It provides information on the critical success factors such as pricing, government programmes etc
• 10 Major players have been profiled providing introduction, financial, operational details of the company.
• The report presents a brief outlook about the regulatory issues and also the regulatory aspects involved in vaccines segment.
• The report provides a future outlook of vaccines market.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.